Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement safety shift of onus to industry counters DSHEA, Amway tells commission.

This article was originally published in The Tan Sheet

Executive Summary

SUPPLEMENT SAFETY BURDEN OF PROOF SHIFT TO INDUSTRY COUNTERS DSHEA, AMWAY maintains in July 24 comments on the President's Commission on Dietary Supplement Labels draft report. The draft report on dietary supplement labeling and claims issues was released June 24; the comment period on the draft ends Aug. 4 ("The Tan Sheet" June 30, pp. 17-25). The draft report states that "the industry as a whole must fully accept the responsibility for assuring the safety of dietary supplements." Amway's Nutrilite Division responds, however, that "the shifting of onus inherent in this presentation back to industry is counter to the letter of [the Dietary Supplement Health & Education Act]....This recommendation from the commission serves the function of altering the letter of the statute."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel